Chemours
551 hedge funds and large institutions have $5.42B invested in Chemours in 2018 Q3 according to their latest regulatory filings, with 68 funds opening new positions, 158 increasing their positions, 177 reducing their positions, and 68 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
551
Holders Change
-6
Holders Change %
-1.08%
% of All Funds
12.62%
Holding in Top 10
6
Holding in Top 10 Change
+1
Holding in Top 10 Change %
+20%
% of All Funds
0.14%
New
68
Increased
158
Reduced
177
Closed
68
Calls
$57.5M
Puts
$95.2M
Net Calls
-$37.7M
Net Calls Change
-$51.8M
Top Buyers
| 1 |
Fidelity Investments
Boston,
Massachusetts
|
+$99.5M |
| 2 |
IAM
Iridian Asset Management
Westport,
Connecticut
|
+$96.2M |
| 3 |
Citadel Advisors
Miami,
Florida
|
+$28.2M |
| 4 |
Marshall Wace
London,
United Kingdom
|
+$22.1M |
| 5 |
CI Investments Inc
Toronto,
Ontario, Canada
|
+$21.8M |
Top Sellers
| 1 |
AQR Capital Management
Greenwich,
Connecticut
|
-$56.8M |
| 2 |
Victory Capital Management
San Antonio,
Texas
|
-$42.8M |
| 3 |
Two Sigma Advisers
New York
|
-$28.2M |
| 4 |
Morgan Stanley
New York
|
-$27.7M |
| 5 |
GCM
Gates Capital Management
New York
|
-$26.5M |
